Literature DB >> 1623631

Human beta-mannosidosis: a 3-year-old boy with speech impairment and emotional instability.

L Poenaru1, S Akli, F Rocchiccioli, P Eydoux, P Zamet.   

Abstract

Beta-mannosidosis is a recently described inherited disorder with predominantly neurological signs and symptoms as the major manifestations of the disorder. The heterogeneous manifestations of the disease have been presented in seven previous patients. We describe a further case of European descent with an infantile onset of the disease, with the features of speech impairment as the first symptom. Beta-mannosidase activity was completely deficient in the patient and a heterozygote level was found in the parents. In addition, mannosyl-N-acetylglucosamine was identified in the patient's urine in keeping with the diagnosis of beta-mannosidosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623631     DOI: 10.1111/j.1399-0004.1992.tb03408.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  A comparative structural bioinformatics analysis of inherited mutations in β-D-Mannosidase across multiple species reveals a genotype-phenotype correlation.

Authors:  Thi Huynh; Javed Mohammed Khan; Shoba Ranganathan
Journal:  BMC Genomics       Date:  2011-11-30       Impact factor: 3.969

2.  β-Mannosidosis caused by a novel homozygous intragenic inverted duplication in MANBA.

Authors:  Maria Blomqvist; Marie Falkenberg Smeland; Julia Lindgren; Per Sikora; Hilde Monica Frostad Riise Stensland; Jorge Asin-Cayuela
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

3.  NFKB1 and MANBA Confer Disease Susceptibility to Primary Biliary Cholangitis via Independent Putative Primary Functional Variants.

Authors:  Yuki Hitomi; Ken Nakatani; Kaname Kojima; Nao Nishida; Yosuke Kawai; Minae Kawashima; Yoshihiro Aiba; Masao Nagasaki; Minoru Nakamura; Katsushi Tokunaga
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-12-04

4.  Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis.

Authors:  Troy C Lund; Weston P Miller; Julie B Eisengart; Katrina Simmons; Laura Pollard; Deborah L Renaud; David A Wenger; Marc C Patterson; Paul J Orchard
Journal:  Mol Genet Genomic Med       Date:  2019-05-21       Impact factor: 2.183

5.  Oral manifestation and dental treatment of pediatric patient with beta-mannosidosis: A case report.

Authors:  Mohammad A Alshoraim; Dania E Al Agili
Journal:  SAGE Open Med Case Rep       Date:  2021-12-15

6.  A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.

Authors:  Frédérique Sabourdy; Pierre Labauge; Hilde Monica Frostad Riise Stensland; Michèle Nieto; Violeta Latorre Garcés; Dimitri Renard; Giovanni Castelnovo; Nicolas de Champfleur; Thierry Levade
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

7.  Beta-mannosidae deficiency in two mentally retarded girls with intractable seizures.

Authors:  Mathew Punnachalil Cherian
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

8.  Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant.

Authors:  Dana Safka Brozkova; Lukas Varga; Anna Uhrova Meszarosova; Zuzana Slobodova; Martina Skopkova; Andrea Soltysova; Andrej Ficek; Jan Jencik; Jana Lastuvkova; Daniela Gasperikova; Pavel Seeman
Journal:  Orphanet J Rare Dis       Date:  2020-08-26       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.